Clincosm LogoSign in Get a demo

follicular lymphoma

Showing 26 - 50 of 267
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

People Living With HIV Treated With CD19-directed CAR T Cell

Active, not recruiting
  • Leukemia
  • +9 more
    • Philadelphia, Pennsylvania
      Pennsylvania Hospital
    Mar 29, 2023

    Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)

    Not yet recruiting
    • Follicular Lymphoma
    • +2 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 13, 2023

    Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult Trial in Boston (Epcoritamab, Rituximab)

    Not yet recruiting
    • Follicular Lymphoma
    • Low Grade Non-Hodgkin's Lymphoma, Adult
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 13, 2023

    Large B-cell Lymphoma, Follicular Lymphoma Trial (Axicabtagene Ciloleucel)

    Available
    • Large B-cell Lymphoma
    • Follicular Lymphoma
    • Axicabtagene Ciloleucel
    • (no location specified)
    Mar 17, 2023

    Advanced Cancer, Follicular Lymphoma, Peripheral T Cell Lymphoma Trial (BR1733)

    Not yet recruiting
    • Advanced Cancer
    • +3 more
    • (no location specified)
    Feb 27, 2023

    Living Conditions of Diffuse Large B-Cell Lymphoma or Follicular

    Completed
    • Diffuse Large Cell Diffuse Lymphoma
    • Follicular Lymphoma
    • Questionnaires
    • Collection of clinical data and treatments
    • Dijon, France
      Chu Dijon Bourogne
    Jan 31, 2023

    Follicular Lymphoma Trial in Australia (Opdivo)

    Active, not recruiting
    • Follicular Lymphoma
    • Ballarat, Victoria, Australia
    • +4 more
    Jan 30, 2023

    B-cell Lymphoma, Non Hodgkin Lymphoma, DLBCL Trial in Louisville (Cyclophosphamide, Fludarabine, ACE1831)

    Recruiting
    • B-cell Lymphoma
    • +5 more
    • Louisville, Kentucky
      Norton Cancer Institute
    Jan 24, 2023

    Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)

    Recruiting
    • Follicular Lymphoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial run by the NCI (Obinutuzumab, Venetoclax, Magrolimab)

    Recruiting
    • Follicular Lymphoma
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

    Recruiting
    • CLL
    • +9 more
    • TG-1801
    • Ublituximab
    • Fayetteville, Arkansas
    • +4 more
    Jan 20, 2023

    Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • New York, New York
      Weill Cornell Medicine/NewYork-Presberteryian Hospital
    Jan 18, 2023

    B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma Trial in Australia, United States (BGB-16673)

    Recruiting
    • B-cell Malignancy
    • +8 more
    • Phoenix, Arizona
    • +14 more
    Jan 17, 2023

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +11 more
    • Zilovertamab vedotin
    • Duarte, California
    • +13 more
    Jan 12, 2023

    CLL/SLL, NHL, Mantle Cell Lymphoma Trial in United States (SYNCAR-001, STK-009, Cyclophosphamide)

    Recruiting
    • CLL/SLL
    • +6 more
    • Duarte, California
    • +4 more
    Jan 12, 2023

    Follicular Lymphoma Trial in Worldwide (Mosunetuzumab (IV), Tocilizumab, Lenalidomide)

    Recruiting
    • Follicular Lymphoma
    • Mosunetuzumab (IV)
    • +3 more
    • Duarte, California
    • +21 more
    Jan 10, 2023

    Follicular Lymphoma Trial in France (Rituximab IV, Rituximab SC)

    Completed
    • Follicular Lymphoma
    • Rituximab IV
    • Rituximab SC
    • Aix En Provence, France
    • +49 more
    Jan 9, 2023

    Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Marginal Zone Lymphoma Trial in France (Atezolizumab, Obinutuzumab,

    Completed
    • Follicular Lymphoma
    • +3 more
    • Angers, France
    • +24 more
    Jan 9, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Follicular Lymphoma Trial in Australia, China (BGB-10188,

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +9 more
    • Adelaide, Australia
    • +12 more
    Jan 6, 2023

    DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,

    Not yet recruiting
    • DLBCL - Diffuse Large B Cell Lymphoma
    • +6 more
    • Bridging radiation therapy
    • +2 more
    • (no location specified)
    Jan 4, 2023

    Follicular Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Seattle (Laboratory Biomarker

    Active, not recruiting
    Has Results
    • Follicular Lymphoma
    • +2 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 6, 2022

    Non-Hodgkin Lymphoma, Follicular Lymphoma, DLBCL Trial in Australia, Korea, Republic of, United States (IGM-2323)

    Recruiting
    • Non-Hodgkin Lymphoma
    • +4 more
    • Duarte, California
    • +23 more
    Dec 28, 2022

    Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

    Active, not recruiting
    • Acute Biphenotypic Leukemia
    • +18 more
    • Aurora, Colorado
    • +2 more
    Dec 28, 2022

    Follicular Lymphoma, Mantle Cell Lymphoma Trial in Rouen (Determination of COVID-19 vacciantion efficacy)

    Completed
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Determination of COVID-19 vacciantion efficacy
    • Rouen, France
      Centre Henri Becquerel
    Dec 22, 2022

    Follicular Lymphoma Trial (Bendamustine, Rituximab, Tazemetostat)

    Not yet recruiting
    • Follicular Lymphoma
    • (no location specified)
    Dec 15, 2022